Global Cancer Treatment Drugs Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Cancer Treatment Drugs Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global cancer treatment drugs market report has been segmented on the basis of drug class type, indication type, and region.
Global Cancer Treatment Drugs Market: Overview
Cancer is a group of diseases containing abnormal cell growth which spread to other parts of the body. Cancer can be treated by various therapies such as radiation therapy, chemotherapy, hormonal therapy. Stages of cancer in patients and disease decides choice of therapy.
Global Cancer Treatment Drugs Market: Dynamics
Rapidly rising prevalence of various type of cancers is expected to boost demand for cancer treatment and drives growth of the target market over the forecast period.
Increasing awareness about cancer and cancer treatment is expected to bolster growth of the global cancer treatment drug market over the forecast period. In addition, availability of various types of advanced drugs for cancer treatment is another factor for the growth of the target market. Increasing research and development activities and government initiatives also propel growth of the target market during the forecast period.
Furthermore, increasing cancer occurrence in geriatric population across the globe is also anticipated to boost demand for the cancer treatment drugs in the next 10 years.
However, adverse side effects of cancer treatment drugs and high cost of treatment are major factors which may hamper demand for cancer treatment drugs and restrain growth of the global market over the forecast period.
Global Cancer Treatment Drugs Market: Segment Analysis
Among the drug class type, the chemotherapy segment is expected to account for highest growth in the global cancer treatment drugs market, owing to less side effects and high treatment efficiency rate. In targeted therapy, cancer treatment drugs block the growth of the targeted cells and restrict spread of cancer by interfering with specific targeted cells.
Among the indication type, the blood cancer segment is expected to contribute significant share in the global cancer treatment drugs market, owing to increasing number of blood cancer patients as compared to other type of cancers over the forecast period. Lung cancer segment is also expected to register moderate growth rate in the global market due to various factors such as smoking, air pollution, and asbestos.
Global Cancer Treatment Drugs Market: Region Analysis
The market in North America accounted for highest revenue share in the global market followed by market in Europe, owing to developed medical infrastructure, favorable reimbursement policies and high adoption of cancer drug in countries in the region.
Market in Asia Pacific is expected to register a lucrative growth in terms of CAGR in the global market, owing to increasing research and development activities and increasing incidences of cancer patient in countries in the region.
Markets in Middle East & Africa and Latin America, are expected to witness moderate growth in terms of revenue, owing to increasing awareness about cancer treatment in countries in these regions.
Global Cancer Treatment Drugs Market Segmentation:
Segmentation by Drug Class Type:
- Targeted Therapy
- Hormonal Therapy
Segmentation by Indication:
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Stomach Cancer
- Colorectal Cancer
- Prostate Cancer
- Esophagus Cancer
- Liver Cancer
- Cervical Cancer
- Bladder Cancer
- Kidney Cancer
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Amgen Inc.
- Johnson & Johnson
- Celgene Corporation
- Eli Lilly and Company
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!